Using Targeted Therapies in a Real-World Setting

Author: Projects In Knowledge, Inc

In this engaging podcast, Drs. Bradley Monk and Robert Burger discuss important practical issues regarding the use of antiangiogenic therapy to treat epithelial ovarian cancer, including the possible value of targeted agents as maintenance therapy, the correct dosage and duration of targeted therapy, and the role of CA125 in determining tumor progression with a biologic agent
Be a guest on this podcast

Language: en-us

Genres: Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data